Debt Disclosure [Abstract] Remainder of 2018 Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months 2019 Long-term Debt, Maturities, Repayments of Principal in Year Two 2020 Long-term Debt, Maturities, Repayments of Principal in Year Three 2021 Long-term Debt, Maturities, Repayments of Principal in Year Four 2022 Long-term Debt, Maturities, Repayments of Principal in Year Five Total long-term debt and lease financing obligations Long-term Debt Investments, Debt and Equity Securities [Abstract] Short-term Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Statement of Comprehensive Income [Abstract] Net loss Net Income (Loss) Attributable to Parent Change in unrealized loss on short-term investments Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Statement of Financial Position [Abstract] Assets Assets [Abstract] Current assets: Assets, Current [Abstract] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Short-term investments Available-for-sale Securities, Current Accounts receivable, net Accounts Receivable, Net, Current Inventory, net Inventory, Net Prepaid expenses and other Prepaid Expense and Other Assets, Current Total current assets Assets, Current Restricted cash Restricted Cash and Cash Equivalents, Noncurrent Property and equipment, net Property, Plant and Equipment, Net Other assets Other Assets, Noncurrent Total assets Assets Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Current liabilities: Liabilities, Current [Abstract] Accounts payable Accounts Payable, Current Accrued liabilities Accrued Liabilities, Current Accrued compensation and other employee benefits Employee-related Liabilities, Current Customer deposits Customer Deposits, Current Deferred revenue, current portion Deferred Revenue, Current Deferred rent, current portion Deferred Rent Credit, Current Total current liabilities Liabilities, Current Deferred revenue, net of current portion Deferred Revenue, Noncurrent Deferred rent and other long-term liabilities Deferred Rent Credit And Liabilities, Other Than Long-term Debt, Noncurrent Deferred Rent Credit And Liabilities, Other Than Long-term Debt, Noncurrent Long-term debt, net of debt issuance costs Long-term Debt and Capital Lease Obligations Total liabilities Liabilities Commitment and contingencies Commitments and Contingencies Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Preferred stock, $0.0001 par value, 15,000 shares authorized; none issued Preferred Stock, Value, Issued Common stock, $0.0001 par value, 150,000 shares authorized; 30,769 and 25,421 shares issued and outstanding at September 30, 2018 and December 31, 2017, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital, Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated deficit Retained Earnings (Accumulated Deficit) Total stockholders’ equity Stockholders' Equity Attributable to Parent Total liabilities and stockholders’ equity Liabilities and Equity Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares authorized (in shares) Common Stock, Shares Authorized Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Accounting Policies [Abstract] Description of Business Business Description and Basis of Presentation [Text Block] Maturing in one year or less Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value Maturing in one to three years Available For Sale Securities Debt Maturities After One Through Three Years Fair Value Available for sale securities debt maturities after one through three years fair value. Total available-for-sale securities Available-for-sale Securities, Debt Securities Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Revenue from Contract with Customer [Abstract] Revenue, Initial Application Period Cumulative Effect Transition [Table] Revenue, Initial Application Period Cumulative Effect Transition [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Retained Earnings Retained Earnings [Member] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition [Domain] Initial Application Period Cumulative Effect Transition [Domain] Calculated under Revenue Guidance in Effect before Topic 606 Calculated under Revenue Guidance in Effect before Topic 606 [Member] Difference between Revenue Guidance in Effect before and after Topic 606 Difference between Revenue Guidance in Effect before and after Topic 606 [Member] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Accounting Standards Update 2014-09 Accounting Standards Update 2014-09 [Member] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Revenue, Initial Application Period Cumulative Effect Transition [Line Items] Cumulative impact of new standard Cumulative Effect of New Accounting Principle in Period of Adoption Revenue recognized during period of adoption Cumulative Effect Of New Accounting Principle In Period Of Adoption, Revenue Recognized Cumulative Effect Of New Accounting Principle In Period Of Adoption, Revenue Recognized Contract liabilities Contract with Customer, Liability Performance obligation satisfied in previous period Contract with Customer, Performance Obligation Satisfied in Previous Period Cash payments received form customers Contract With Customer, Liability, Increase From Cash Receipts Contract With Customer, Liability, Increase From Cash Receipts Contract assets Contract with Customer, Asset, Net Remaining performance obligation Revenue, Remaining Performance Obligation Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Schedule of New Accounting Pronouncements and Changes in Accounting Principles Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] Americas Americas [Member] Europe and Middle East Europe And Middle East [Member] Europe And Middle East [Member] Asia Pacific Asia Pacific [Member] Products and Services [Axis] Products and Services [Axis] Products and Services [Domain] Products and Services [Domain] Instruments Product, Instruments [Member] Product, Instruments [Member] Consumables Product, Consumables [Member] Product, Consumables [Member] In vitro diagnostic kits Product, In Vitro Diagnostic Kits [Member] Product, In Vitro Diagnostic Kits [Member] Total product revenue Product [Member] Service revenue Service [Member] Service [Member] Total product and service revenue Product And Service [Member] Product And Service [Member] Collaboration revenue Collaboration [Member] Collaboration [Member] Revenue Revenue from Contract with Customer, Excluding Assessed Tax Risks and Uncertainties [Abstract] Concentration Risk [Table] Concentration Risk [Table] Customer [Axis] Customer [Axis] Customer [Domain] Customer [Domain] Lam Research Corporation Lam Research Corporation [Member] Lam Research Corporation Merck Sharp & Dohme Corp. Medivation, Inc. and Astellas Pharma, Inc. [Member] Medivation, Inc. and Astellas Pharma, Inc. [Member] Merck Sharp & Dohme Corp. Merck Sharp And Dohme Corporation [Member] Merck Sharp And Dohme Corporation [Member] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Concentration Risk Type [Domain] Concentration Risk Type [Domain] Customer Concentration Risk Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Total revenue Sales Revenue, Net [Member] Concentration Risk [Line Items] Concentration Risk [Line Items] Concentration risk percentage Concentration Risk, Percentage Long-term Debt Debt Disclosure [Text Block] Significant Accounting Policies [Table] Significant Accounting Policies [Table] A summary of information pertaining to the Basis of Presentation and Summary of Significant Accounting Policies disclosure as a whole for which no other established gaap taxonomy identified hypercube is available. Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Significant Accounting Policies [Line Items] Significant Accounting Policies [Line Items] Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Extended warranty period Extended Product Warranty Period The extended product warranty liability period. Does not include increases or decreases in the standard warranty liability. Standard warranty period Standard Product Warranty Period The standard product warranty liability period. Does not include increases or decreases in an extended warranty liability. Line of Credit Facility [Table] Line of Credit Facility [Table] Variable Rate [Axis] Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Prime Rate Prime Rate [Member] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Term Loan Agreement Term Loan Agreement [Member] Term Loan Agreement [Member] Secured Revolving Loan Facility Secured Revolving Loan Facility [Member] Secured Revolving Loan Facility [Member] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Variable rate Debt Instrument, Basis Spread on Variable Rate Credit facility, additional borrowing capacity Line Credit Facility Additional Borrowing Capacity Line Credit Facility Additional Borrowing Capacity Unused borrowing capacity, amount Debt Instrument, Unused Borrowing Capacity, Amount Percentage of accrue interest Long-term Debt, Percentage Bearing Fixed Interest, Percentage Rate Percentage of deferred payment Deferred Payment Obligation Accrued Interest Rate Payment-in-kind percentage as agreed upon in the financing agreement to defer interest payments. Interest deferral period Debt Instrument, Interest Deferral Period Debt Instrument, Interest Deferral Period Deferred interest payment Debt, Deferred Interest Payment Debt, Deferred Interest Payment Term loans payable Loans Payable Interest payment period Debt Instrument, Interest Payment Period Debt Instrument, Interest Payment Period Number of installments Debt Instrument, Number Of Installments During Eighth Year Of Term Debt Instrument, Number of Installments During Eighth Year of Term Percentage payment up on repayment of principal amount Line of Credit Facility, Commitment Fee Percentage Long term liability Long-term Line of Credit, Noncurrent Minimum liquidity Minimum Liquidity Covenant Amount Minimum Liquidity Covenant Amount Annual revenue requirements Revenue Recognition, Milestone Method, Revenue Recognized Increase in annual revenue in fiscal years Increased Annual Revenues Increased Annual Revenues Long-term Line of Credit Long-term Line of Credit Statement of Cash Flows [Abstract] Statement [Table] Statement [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Statement [Line Items] Statement [Line Items] Operating activities Net Cash Provided by (Used in) Continuing Operations [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization Stock-based compensation expense Allocated Share-based Compensation Expense Amortization of premium on short-term investments Investment Income, Net, Amortization of Discount and Premium Amortization of deferred financing costs Interest Accrued On Long Term Notes Interest expense incurred, not yet paid, on all other long-term debt, which may include (1) interest on long-term notes, and (2) amortization of issuance costs not otherwise separately disclosed. Conversion of accrued interest to long-term debt Conversion Of Accrued Interest To Long Term Debt Conversion Of Accrued Interest To Long Term Debt Provision for bad debts Provision for Doubtful Accounts Inventory Write-down Inventory Write-down Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Increase (Decrease) in Inventories Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Accounts payable Increase (Decrease) in Accounts Payable Accrued liabilities Increase (Decrease) in Accrued Liabilities Accrued compensation and other employee benefits Increase (Decrease) in Employee Related Liabilities Customer deposits Increase (Decrease) in Customer Deposits Deferred revenue Increase (Decrease) in Deferred Revenue Deferred rent and other liabilities Increase (Decrease) In Deferred Rent And Other Operating Liabilities Increase (Decrease) in Deferred Rent and Other Operating Liabilities Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Purchases of property and equipment Payments to Acquire Property, Plant, and Equipment Proceeds from sale of short-term investments Proceeds from Sale of Short-term Investments Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities Purchases of short-term investments Payments to Acquire Available-for-sale Securities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Repayment of lease financing obligations Repayments of Long-term Capital Lease Obligations Proceeds from sale of common stock, net Proceeds from Issuance of Common Stock Proceeds from issuance of common stock warrants Proceeds from Issuance of Warrants Deferred financing costs Payment of Financing and Stock Issuance Costs Tax withholdings related to net share settlements of restricted stock units Restricted Stock, Value, Shares Issued Net of Tax Withholdings Proceeds from issuance of common stock for employee stock purchase plan Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Excluding Stock Options Proceeds from exercise of stock options Proceeds from Stock Options Exercised Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Net (decrease) increase in cash, cash equivalents and restricted cash Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Effect of exchange rate changes on cash and cash equivalents and restricted cash Effect of Exchange Rate on Cash and Cash Equivalents Cash and cash equivalents and restricted cash Cash and Cash Equivalents, at Carrying Value [Abstract] Beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents End of period Cash and cash equivalents Restricted cash Restricted Cash Summary of Shares Underlying Outstanding Options and Warrants were Excluded from Computation of Basic and Diluted Net Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Segment Reporting [Abstract] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] United States UNITED STATES Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Number of sales forces Number Of Sales Forces Number of Sales Forces Number of reportable segment Number of Reportable Segments Total revenue Revenues Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Unamortized debt issuance costs Unamortized Debt Issuance Expense Long-term debt, net of debt issuance costs Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Reclassifications Reclassification, Policy [Policy Text Block] Revenue Recognition Revenue Recognition, Policy [Policy Text Block] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Net Loss Per Share Earnings Per Share, Policy [Policy Text Block] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Information about Geographic Areas Segment Reporting Disclosure [Text Block] Document And Entity Information [Abstract] Document And Entity Information. Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Components of Borrowings, Including Current Portion Schedule of Debt [Table Text Block] Scheduled Future Principal Payments under Outstanding Debt Obligations Schedule of Maturities of Long-term Debt [Table Text Block] Short-Term Investments Available-for-Sale Securities Available-for-sale Securities [Table Text Block] Fair Values of Available-for-Sale Securities by Contractual Maturity Investments Classified by Contractual Maturity Date [Table Text Block] Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block] Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value [Table Text Block] Company's Available-for-Sale Securities by Level within Fair Value Hierarchy Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Axis] Major Types of Debt and Equity Securities [Domain] Major Types of Debt and Equity Securities [Domain] Corporate debt securities Corporate Debt Securities [Member] U.S. government-related debt securities US Government Agencies Debt Securities [Member] Asset-backed Securities [Member] Asset-backed Securities [Member] Schedule of Available-for-sale Securities [Line Items] Schedule of Available-for-sale Securities [Line Items] Less Than 12 Months, Fair value Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value Less Than 12 Months, Gross unrealized losses Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss 12 Months or Greater, Fair value Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value 12 Months or Greater, Gross unrealized losses Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss Total, Fair value Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value Total, Gross unrealized losses Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss Equity [Abstract] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Sale of Stock [Axis] Sale of Stock [Axis] Sale of Stock [Domain] Sale of Stock [Domain] At The Market Equity Offering At The Market Equity Offering [Member] At The Market Equity Offering [Member] Public Stock Offering Public Stock Offering [Member] Public Stock Offering [Member] Over-Allotment Option [Member] Over-Allotment Option [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary, Sale of Stock [Line Items] Commission expense, percentage Commission Expense, Percentage Commission Expense, Percentage Shares sold in offering Sale of Stock, Number of Shares Issued in Transaction Total gross proceeds from stock offering Sale Of Stock, Gross Consideration Received On Transaction Sale Of Stock, Gross Consideration Received On Transaction Aggregate net proceeds from stock offering Sale of Stock, Consideration Received on Transaction Europe & Middle East EMEA [Member] Product and service Revenue, Net Collaboration License and Services Revenue Recognition of Deferred Revenue Recognition of Deferred Revenue Net loss per share - basic and diluted (in dollars per share) Earnings Per Share, Basic and Diluted Inventory Disclosure [Abstract] Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Raw materials Inventory, Raw Materials, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Inventory, net Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Total Products And Services Total Products And Services [Member] Total Products And Services [Member] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Income Statement [Abstract] Revenue: Revenues [Abstract] Total revenue Costs and expenses: Costs and Expenses [Abstract] Cost of product and service revenue Cost of Revenue Research and development Research and Development Expense Selling, general and administrative Selling, General and Administrative Expense Total costs and expenses Costs and Expenses Loss from operations Operating Income (Loss) Other income (expense): Other Income and Expenses [Abstract] Interest income Investment Income, Interest Interest expense Investment Income, Investment Expense Other income (expense), net Other Nonoperating Income (Expense) Total other income (expense), net Nonoperating Income (Expense) Net loss before provision for income tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Provision for income tax Income Tax Expense (Benefit) Net loss Weighted average shares used in computing basic and diluted net loss per share (in shares) Weighted Average Number of Shares Outstanding, Basic and Diluted Concentration of Risks Concentration Risk Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Event [Table] Subsequent Event [Table] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] June 30, 2019 Debt Instrument, Redemption, Period One [Member] After December 31, 2019 Debt Instrument, Redemption, Period Two [Member] CRG Servicing LLC Amended and Restated Loan Agreement CRG Servicing LLC Amended And Restated Loan Agreement [Member] CRG Servicing LLC Amended And Restated Loan Agreement [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent event Subsequent Event [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Proceeds from debt net of debt extinguishment and costs Proceeds From Issuance Of Long Term Debt, Net Of Debt Extinguishment And Issuance Cost Proceeds From Issuance Of Long Term Debt, Net Of Debt Extinguishment And Issuance Cost Proceeds from borrowings Proceeds from Issuance of Long-term Debt Additional borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Credit facility, additional borrowing capacity Line of Credit Facility, Current Borrowing Capacity Upfront fee of aggregate principal amount (as a percentage) Upfront Fee Of Aggregate Principal Amount, Percentage Upfront Fee Of Aggregate Principal Amount, Percentage Number of warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Exercise price per share (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Number of additional warrants to be issued on future draw, percentage of diluted shares outstanding (as a percentage) Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights, Future Draw, Percentage Of Diluted Shares Outstanding Class Of Warrant Or Right, Number Of Securities Called By Warrants Or Rights, Future Draw, Percentage Of Diluted Shares Outstanding Percentage premium to average closing trading price (as a percentage) Class of Warrant or Right, Exercise Price of Warrants or Rights, Percentage Premium To Average Closing Trading Price Class of Warrant or Right, Exercise Price of Warrants or Rights, Percentage Premium To Average Closing Trading Price Deferred Revenue Disclosure [Abstract] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Type of Arrangement and Non-arrangement Transactions [Axis] Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Arrangements and Non-arrangement Transactions [Domain] Collaborative Arrangement Collaborative Arrangement [Member] Counterparty Name [Axis] Counterparty Name [Axis] Counterparty Name [Domain] Counterparty Name [Domain] Celgene Corporation Celgene Corporation [Member] Celgene Corporation [Member] Deferred Revenue Arrangement Type [Axis] Deferred Revenue Arrangement Type [Axis] Deferred Revenue [Domain] Deferred Revenue [Domain] Upfront Payment Arrangement Up-front Payment Arrangement [Member] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Maximum amount of royalties payable (ratio) Maximum Amount Of Royalties Payable, Ratio To License And Service Revenue Maximum Amount Of Royalties Payable, Ratio To License And Service Revenue Maximum number of employees Reimbursement Of Counterparty Costs, Maximum Number Of Employees Reimbursement Of Counterparty Costs, Maximum Number Of Employees Number of warrants, outstanding Class of Warrant or Right, Outstanding Exercise price of warrants Exercise Price Of Common Stock Warrants Exercise Price Of Common Stock Warrants Issued warrants, value Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants Proceeds from collaborators Proceeds from Collaborators Deferred revenue recorded under collaboration agreement Deferred Revenue Estimated deferred revenue recognized within one year Collaborative agreement period Collaborative Agreement Period Of Contract Collaborative Agreement Period Of Contract Customer deposits Other Liabilities, Current nstg_ReimbursementOfCounterpartyCosts nstg_ReimbursementOfCounterpartyCosts nstg_ReimbursementOfCounterpartyCosts Amounts due for services provided Collaborative Agreement, Accrued Cost Collaborative Agreement, Accrued Cost Payments for services provided Payments For Collaborative Agreement Payments For Collaborative Agreement Number of warrants exercised Class Of Warrant Or Right, Number Of Warrants Or Rights Exercised Class Of Warrant Or Right, Number Of Warrants Or Rights Exercised Maximum success-based milestone payments Collaboration agreement upfront payment Deferred Revenue, Additions Classification of Revenue by Geography Revenue from External Customers by Geographic Areas [Table Text Block] Revenue from Contracts with Customers Revenue from Contract with Customer [Text Block] Amortized cost Available-for-sale Securities, Amortized Cost Basis Gross unrealized gains Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax Gross unrealized losses Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax Fair value Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Level 1 Fair Value, Inputs, Level 1 [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Level 3 Fair Value, Inputs, Level 3 [Member] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Money market fund Money Market Funds [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total Assets, Fair Value Disclosure Subsequent Event Subsequent Events [Text Block] Collaboration Agreements Collaborative Arrangement Disclosure [Text Block] Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Inventory Inventory Disclosure [Text Block] Investments that were other-than-temporarily impaired Other than Temporary Impairment Losses, Investments, Available-for-sale Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Options to purchase common stock Employee Stock Option [Member] Restricted stock units Restricted Stock Units (RSUs) [Member] Common stock warrants Warrant [Member] Common Stock Common Stock [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount